ATG-207
/ Antengene
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 15, 2026
Innovative Treatment for Autoimmune Diseases: Globally First-in-Class ATG-207
(PRNewswire)
- "The Company plans to present the preclinical data for ATG-207 for the first time at an international scientific conference in 2026."
Preclinical • Immunology
1 to 1
Of
1
Go to page
1